Related Experiment Video

Updated: May 16, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

Rho GTPases and their roles in cancer metabolism

Kristin F Wilson1, Jon W Erickson, Marc A Antonyak

  • 1Department of Molecular Medicine, Cornell University, Ithaca, NY 14853-6401, USA.

Trends in Molecular Medicine
|December 11, 2012
PubMed

Insights

Small molecule 968 targets mitochondrial glutaminase (GLS1), revealing a link between Rho GTPases and cancer cell metabolism. This discovery offers new insights into glutamine metabolism

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Cancer cells exhibit altered metabolic demands.
  • Rho GTPases regulate cancer cell growth.
  • Mitochondrial glutamine metabolism is crucial for cancer progression.

Purpose of the Study:

  • To review the mechanism of glutaminase activation in cancer cells.
  • To compare glutaminase inhibitors.
  • To discuss the role of glutamine metabolism in cancer progression.

Main Methods:

  • Small molecule 968 as a glutaminase inhibitor.
  • Investigating Rho GTPase signaling.
  • Analyzing mitochondrial glutamine metabolism in cancer cells.

Main Results:

  • Small molecule 968 inhibits Rho GTPase-dependent cancer cell growth.
  • GLS1 is identified as the target of small molecule 968.
  • Rho GTPases and NF-κB signaling elevate mitochondrial glutaminase activity in cancer cells.

Conclusions:

  • A novel link exists between Rho GTPases and mitochondrial glutamine metabolism.
  • Targeting glutaminase offers a potential therapeutic strategy for cancer.
  • Understanding glutamine metabolism is key to cancer progression research.

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...